A Phase 1 Study of LBL-051 in Patients with Refractory Autoimmune Disease

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525621-20-00

Enrollment

Registered

2026-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B-cell–mediated autoimmune diseases

None listed

Sex/Gender

All

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Jun 26, 2026